BMI View: Continued political instability coupled with a bleak economic outlook will continue to repress
the pharmaceutical and healthcare sectors in Croatia. Necessary austerity measures will impose further
barriers towards growth and reduce the use of high-value patented drugs, highlighting minimal revenue
earning opportunities for multinational pharmaceutical firms.
Headline Expenditure Projections
? Pharmaceuticals: HRK6.73bn (USD961mn) in 2015 to HRK6.76bn (USD931mn) in 2016; 0.5% in
local currency and -3.2% in US dollar terms. Forecast revised upwards compared with Q116.
? Healthcare: HRK21.99bn (USD3.14bn) in 2015 to HRK21.66bn (USD2.99bn) in 2016; -1.5% in local
currency and -5.1% in US dollar terms. Forecast revised slightly upwards compared with Q116.

Table of Contents

BMI Industry View 7
Table: Headline Pharmaceuticals & Healthcare Forecasts (Croatia 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Croatia 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Croatia 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Croatia 2012-2020) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Croatia 2012-2020) 16
Prescription Drug Market 17
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Croatia 2012-2020) 19
Patented Drug Market Forecast 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Croatia 2012-2020) 21
Generic Drug Market Forecast 22
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Croatia 2012-2020) 23
OTC Medicine Market Forecast 24
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Croatia 2012-2020) 25
Pharmaceutical Trade Forecast 26
Table: Pharmaceutical Trade Data And Forecasts (Croatia 2014-2020) 27
Table: Pharmaceutical Trade Data And Forecasts local currency (Croatia 2014-2020) 27
Industry Risk Reward Index 28
Central And Eastern Europe Risk/Reward Index 28
Croatia Risk/Reward Index 34
Rewards 34
Risks 35
Regulatory Review 36
Intellectual Property Issues 38
Pricing Regime 38
Table: New Profit Margins For Wholesalers 40
Reimbursement Regime 40
Risk Sharing Schemes 42
Pharmaceutical Cost-Effectiveness Measures 42
OTC Regulations 42
Generic Regulations 43
Biosimilars 43
Market Overview 44
Healthcare Sector 45
Table: Healthcare Resources (Croatia 2010-2015) 45
Table: Healthcare Personnel (Croatia 2010-2015) 45
Table: Healthcare Activity (Croatia 2010-2015) 46
Table: Reimbursed Drug Expenditure By HZZO (HRKbn) - Equivalent To Final Consumer Prices 47
Research & Development 48
Clinical Trials 49
Epidemiology 50
Table: Cancer Incidence Rates, 2010-2035 52
Competitive Landscape 54
Research-Based Industry 54
Table: Multinational Market Activity 55
Generic Drugmakers 56
Pharmaceutical Distribution 56
Pharmaceutical Retail 57
Company Profile 58
Belupo 58
Jadran Galenski Laboratorij 61
PLIVA 63
Demographic Forecast 66
Table: Population Headline Indicators (Croatia 1990-2025) 67
Table: Key Population Ratios (Croatia 1990-2025) 67
Table: Urban/Rural Population & Life Expectancy (Croatia 1990-2025) 68
Table: Population By Age Group (Croatia 1990-2025) 68
Table: Population By Age Group % (Croatia 1990-2025) 69
Glossary 71
Methodology 73
Pharmaceutical Expenditure Forecast Model 73
Healthcare Expenditure Forecast Model 73
Notes On Methodology 74
Risk/Reward Index Methodology 75
Index Overview 76
Table: Pharmaceutical Risk/Reward Index Indicators 76
Indicator Weightings 77

List of Tables

Table: Headline Pharmaceuticals & Healthcare Forecasts (Croatia 2014-2020)
Table: Pharmaceutical Sales, Historical Data And Forecasts (Croatia 2012-2020)
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Croatia 2012-2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Croatia 2012-2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Croatia 2012-2020)
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Croatia 2012-2020)
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Croatia 2012-2020)
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Croatia 2012-2020)
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Croatia 2012-2020)
Table: Pharmaceutical Trade Data And Forecasts (Croatia 2014-2020)
Table: Pharmaceutical Trade Data And Forecasts local currency (Croatia 2014-2020)
Table: New Profit Margins For Wholesalers
Table: Healthcare Resources (Croatia 2010-2015)
Table: Healthcare Personnel (Croatia 2010-2015)
Table: Healthcare Activity (Croatia 2010-2015)
Table: Reimbursed Drug Expenditure By HZZO (HRKbn) - Equivalent To Final Consumer Prices
Table: Cancer Incidence Rates, 2010-2035
Table: Multinational Market Activity
Table: Population Headline Indicators (Croatia 1990-2025)
Table: Key Population Ratios (Croatia 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Croatia 1990-2025)
Table: Population By Age Group (Croatia 1990-2025)
Table: Population By Age Group % (Croatia 1990-2025)
Table: Pharmaceutical Risk/Reward Index Indicators